TrialBritish journal of clinical pharmacology2019

Pharmacokinetics, safety and tolerability of the novel β-hCG derived immunomodulatory compound, EA-230.

Roger van Groenendael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.